Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mithun Vinod Shah
Observed name:
Mithun V. Shah
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
ORCID:
0000-0002-5359-336X
Observed ORCID:
0000-0002-5359-336X
OpenAlex ID:
A5136557994
Determinants of survival in 356 patients failing frontline HMA-Ven for newly-diagnosed AML.
2026
·
Mahnoor Fatima
, Sudhesh Kumar
, et al.
·
Journal of Clinical Oncology
HMA plus venetoclax for 7- vs 14- vs 21- vs 28-day cycles in newly-diagnosed acute myeloid leukemia: ELN- and Mayo Genetic Risk–stratified analysis in 540 patients.
2026
·
Sudhesh Kumar
, Momna Warraich
, et al.
·
Journal of Clinical Oncology
Older age as a predictor of post-transplant survival in newly diagnosed acute myeloid leukemia treated with HMA-venetoclax.
2026
·
Momna Warraich
, Sudhesh Kumar
, et al.
·
Journal of Clinical Oncology
Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significance
2026
·
Yazan Jabban
, Rong He
, et al.
·
Haematologica
PDF
Mutational profiling links biologically relevant variants to multisystemic Rosai-Dorfman disease
2026
·
Gordon J. Ruan
, Steven Tessier
, et al.
·
Blood Advances
Show more works
View as search
Works count:
6
Citation count:
H-index:
I10-index:
Year
Topic
Type
